The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways

International Archives of Allergy and Immunology

Volumn 152, Issue 3, 2010, Pages 295-300

  Fukuda, Hironobu ^a   Abe, Toshio ^a   Yoshihara, Shigemi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Airway; Antigen challenge; C fibers; Cannabinoid; Guinea pig; Plasma extravasation; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; EVANS BLUE; MEMBRANE METALLOENDOPEPTIDASE; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; OVALBUMIN; PHOSPHORAMIDON; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DOSE COMPARISON; EXTRAVASATION; GUINEA PIG; MALE; NERVE FIBER C; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; TRACHEA;

ANIMALS; ANTIGENS; BENZOXAZINES; BORNANES; CAPILLARY PERMEABILITY; DIPEPTIDES; EVANS BLUE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; GUINEA PIGS; IMMUNIZATION; INDOLES; INFLAMMATION; MALE; MORPHOLINES; NAPHTHALENES; OVALBUMIN; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, NEUROKININ-1; RESPIRATORY HYPERSENSITIVITY; TRACHEA;

EID: 76249102815     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000283042     Document Type: Article

References (43)

1. Barnes PJ: Neuroeffector mechanisms: the interface between inflammation and neuronal responses. J Allergy Clin Immunol 1996; 98:S73-S83.
2. Joos GF, Pauwels RA: Tachykinin receptor antagonists: potential in airways diseases. Curr Opin Pharmacol 2001; 1: 235-241.
3. Murai M, Morimoto H, Maeda Y, Fujii T: Effects of the tripeptide substance P antagonist, FR 113680, on airway constriction and airway edema induced by neurokinins in guinea-pigs. Eur J Pharmacol 1992; 217: 23-27.
4. Murai M, Morimoto H, Maeda Y, Kiyotoh S, Nishikawa M, Fujii T: Effects of FK 224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea-pigs. J Pharmacol Exp Ther 1992; 262: 403-408.
5. Morimoto H, Yamashita M, Matsuda A, Miyake H, Fujii T: Effects of FR 113680 and FK224, novel tachykinin antagonists, on cigarette smoke-induced rat tracheal plasma extravasation. Eur J Pharmacol 1992; 224: 1-5.
6. Bertrand C, Geppetti P, Baker J, Yamawaki I, Nadel JA: Role of neurogenic inflammation in antigen-induced vascular extravasation in guinea pig trachea. J Immunol 1993; 150: 1497-11485
7. Yoshihara S, Geppeeti P, Linden A, Hara M, Chan B, Nadel JA: Tachykinins mediate the potentiation of antigen-induced bronchoconstriction by cold air in guinea pigs. J Allergy Clin Immunol 1996; 97: 756-760.
8. Yoshihara S, Chan B, Yamawaki I, Pierangelo G, Ricciardolo FLM, Massion PP, Nadel JA: Plasma extravasation in the rat trachea induced by cold air is mediated by tachykinin release from sensory nerves. Am J Respir Crit Care Med 1995; 151: 1011-1017.
9. Ono M, Abe T, Watanabe M, Yamada Y, Yoshihara S: Nedocromil sodium inhibits hypertonic saline-induced plasma extravasation in guinea-pig airways. Biomed Res 1999; 20: 233-238.
10. Cui Y, D'Agostio B, Risse PA, Marrocco G, Naline E, Zhang Y, Chen HZ, Finance O, Rinaldi-Carmmona M, Rossi F, Advenier C: Cannabinoid CB2 receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux. Eur J Pharmacol 2007; 573: 206-213.
11. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-824.
12. Morimoto H, Matsuda A, Ohori M, Fujii T: Effects of -conotoxin GVIA on the activation of capsaicin-sensitive afferent sensory nerves in guinea pig airway tissues. Jpn J Pharmacol 1996; 71: 161-166.
13. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG: International Union of Pharmacology. 27. Classification of cannabinoid receptors. Pharmacol Rev 2002; 54: 161-202. (Pubitemid 34575709)
14. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of peripheral receptor for cannabinoids. Nature 1993; 365: 61-65.
15. Glass M, Dragunow M, Faull RL: Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997; 77: 299-318.
16. Griffin G, Fernando SR, Ross RA, Mckay NG, Ashford ML, Shire D, Huffman JW, Yu S, Lainton JA, Pertwee RG: Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol 1997; 339: 53-61.
17. Howlett AC, Johnson MR, Melvin LS, Mine GM: Nonclassical cannabinoid analgesics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol Pharmacol 1988; 33: 297-302.
18. Mackie KY, Westenbroek LR, Mitchell R: Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Qtype calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 1995; 15: 6552-6561.
19. Caulfield MP, Brown DA: Cannabinoid receptor agonists inhibit Ca current in NG108-
20. neuroblastoma cells via a pertussis toxinsensitive mechanism. Br J Pharmacol 1992; 106: 231-232.
21. Mackie K, Hille B: Cannabinoids inhibit Ntype calcium channels in neuroblastomaglioma cells. Proc Natl Acad Sci USA 1992; 89: 3825-3829.
22. Fox AJ, Barnes PJ, Venkatesan P, Belvisi MG: Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. J Clin Invest 1997; 99: 513-519.
23. Yoshihara S, Morimoto H, Yamada Y, Abe T, Arisaka O: Cannabinoid receptor agonists inhibit sensory nerve activation in guinea pig airways. Am J Respir Crit Care Med 2004; 170: 941-946.
24. Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O: The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues. J Pharmacol Sci 2005; 98: 77-82.
25. Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O: Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways. Int Arch Allergy Immunol 2005; 138: 80-87.
26. Giannini L, Nistri S, Mastroianni R, Cinci L, Vannacci A, Mariottini C, Passani MB, Mannaioni PF, Bani D, Masini E: Activation of cannabinoid receptors prevents antigeninduced asthma-like reaction in guinea pigs. J Cell Mol Med 2008; 12: 2381-2394.
27. Dunn CJ, Elliott GA, Oostveen JA, Richards IM: Development of a prolonged eosinophilrich inflammatory leukocyte infiltration in the guinea pig asthmatic response to ovalbumin inhalation. Am Rev Respir Dis 1988; 137: 541-547.
28. Yoshihara S, Riccardolo FL, Geppetti P, Linden A, Hara M, Chan B, Nadel JA: Corticotropin- releasing factor inhibits antigen-induced plasma extravasation in airways. Eur J Pharmacol 1995; 280: 113-118.
29. Watanabe M, Yoshihara S, Abe T, Oyama M, Arisaka O: Effects of orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma extravasation in guinea pig airways. Eur J Pharmacol 1999; 367: 373-378.
30. Bertrand C, Geppetti P, Baker J, Petersson G, Piedimonte G, Nadel JA: Role of peptidases and NK1 receptors in vascular extravasation induced by bradykinin in rat nasal mucosa. J Appl Physiol 1993; 74: 2456-2461.
31. Piedimont G, Bertrand C, Geppetti P, Snider RM, Desai MC, Nadel JA: A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypotonic saline. J Pharmacol Exp Ther 1993; 266: 270-273.
32. Lundberg JM, Saria A: Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature 1983; 302: 251-253.
33. Pertwee RG, Ross RA: Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 101-121.
34. Huffman JW, Liddle J, Yu S, Aung MM, Abood ME, Wiley JL, Martin BR: 3-(1',1'-Dimethylbutyl)- 1-deoxy-D8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg Med Chem 1999; 7: 2905-2914.
35. Regoli D, Drapeau G, Dion S, D'Orleans- Juste P: Pharmacological receptors for substance P and neurokinins. Life Sci 1987; 40: 109-117.
36. Regoli D, Drapeau G, Dion S, Counter R: New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Trends Pharmacol Sci 1988; 9: 290-295.
37. Joos G, Pauwels R, Van Der Straeten: Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax 1987; 42: 779-783.
38. Holzer P: Local effector functions of capsaicin- sensitive sensory nerve endings: involvement of tachykinins, calcitonin generelated peptide and other neuropeptides. Neuroscience 1988; 24: 739-768.
39. Stretton D: Non-adrenergic, non-cholinergic neural control of the airways. Clin Exp Pharmacol Physiol 1991; 18: 675-684
40. Watanabe N, Horie S, Michael GJ, Spina D, Page CP, Priestley JV: Immunohistochemical localization of vanilloid receptor subtype 1 (TRPV1) in the guinea pig respiratory system. Pulm Pharmacol Ther 2005; 18: 187-197.
41. Watanabe N, Horie S, Michael GJ, Keir S, Spina D, Page CP, Priestley JV: Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV1) and sensory neuropeptides in the guinea-pig respiratory system. Neuroscience 2006; 141: 1533-1543.
42. La Rana G, Russo R, D'Agostino G, Sasso O, Raso GM, Iacono A, Meli R, Piomelli D, Calignano A: AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: role for cannabinoid receptors. Neurophamacology 2008; 54: 521-529.
43. Yoshihara S, Ono M, Yamada Y, Fukuda N, Abe T, Arisaka O: Nedocromil sodium inhibits bradykinin- and antigen-induced plasma extravasation in guinea pig airways. Biomed Res 2001; 22: 19-24.